NAU-TGen North Dangerous Pathogens DNA Forensics Center Upgrade
Technical Report,08 Sep 2011,07 Apr 2014
Northern Arizona University Flagstaff United States
Pagination or Media Count:
Despite its importance for infectious disease diagnosis, the ability to rapidly identify the causative agent for infections remains an elusive. Whole genome sequencing for clinical diagnostics is emerging as the future of disease identification and management by providing a rapid and highly sensitive method of diagnosing and characterizing infection. We have created a metagenomic application for analysis of clinical samples titled MetaGenomics Explorer MetaGeniE, previously called IRIMASthat is undergoing optimization and statistical validation with a range of different datasets. MetaGeniE provides novel insights and analyses of clinical datasets, detecting and characterizing the major component of community that is usually the infectious agent of interest as well as identifying the other microbes in this community. Furthermore, we are able to validate these detections with laboratory culture, and available patient information. Finally, we are able to take these analyses a step beyond nearly all current approaches and can use both SNP genotyping and determine features such as antibiotic resistance to precisely characterize these pathogens.
- Medicine and Medical Research
- Genetic Engineering and Molecular Biology